Sputnik V Produced at Torlak Approved for Use

Source: eKapija Wednesday, 01.09.2021. 11:48
Comments
Podeli
Illustration (Photo: Pixabay.com/Alexey Fedenkov)Illustration
The minister without a portfolio in charge of innovations and technological development at the Government of the Republic of Serbia, Nenad Popovic, has announced that the Russian Gamaleya Institute has approved the use of 550,000 doses of the Sputnik V vaccine produced at the Torlak Institute by August 13.

Popovic said on RTS that the Gamaleya Institute had approved the use of vaccines from Torlak the night before and that they were of the exact same quality as those produced in Russia, as announced on the website of the Government of Serbia.

He explained that 18 parameters had been controlled on 960 samples in line with the highest global standards and that they had all had excellent results and noted that the vaccines were ready for use.


– We have 550,000 doses – 275,000 components 1 and 275,000 components 2, ready for use here in Serbia, which were produced in Serbia – the minister pointed out and added that “the decision on the potential export will be reached by the Government of Serbia and president Aleksandar Vucic”.

According to him, there needs to be an agreement with the Russian partners as to an authorization for the export, so as to avoid a simultaneous export to the same markets by both sides.

Comments
Your comment
Full information is available only to commercial users-subscribers and it is necessary to log in.

Forgot your password? Click here HERE

For free test use, click HERE

Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno, uz konsultacije sa našim ekspertima.